Session Details

[P-PR](+)RNA

Tue. Oct 29, 2019 11:00 AM - 5:00 PM JST
Tue. Oct 29, 2019 2:00 AM - 8:00 AM UTC
Poster Room Exhibition Hall
Viewing

[P-PR-01]Development of a recombinant vaccine against human coronavirus associated severe pneumonia

*Hanako Sekimukai1,2, Naoko Iwata-Yoshikawa1, Syuetsu Fukushi3, Aiko Fukuma3,5, Hideki Tani4,3, Hideki Hasegawa1, Noriyo Nagata1 (1. Department of Pathology, National Institute of Infectious Diseases, 2. Tokyo University of agriculture and technology, 3. Department of Virology I, National Institute of Infectious Diseases, 4. The University of Toyama Department of Virology, 5. Shimane Prefectural Institute of Public Health and Environmental Science)

[P-PR-02]An ultra-rapid real-time RT-PCR for the detection of Middle East respiratory syndrome coronavirus using mobile PCR device, PCR1100

*Kazuya Shirato1, Naganori Nao1, Shutoku Matsuyama1, Tsutomu Kageyama2 (1. Department of Virology III, National Institute of Infectious Diseases, 2. Influenza Virus Research Center, National Institute of Infectious Diseases)

[P-PR-03]Imaging analysis on pathogenicity of porcine epidemic diarrhea virus spike recombinants

*Tohru Suzuki1, Seiichi Ohashi1, Wataru Kamitani2 (1. National Institute of Animal Health, 2. Research Institute of Microbial Diseases)

[P-PR-04]Middle East respiratory syndrome coronavirus ORF4b inhibits IKKα-mediated phosphorylation of IRF7 involved in activation of the alpha interferon gene

*Yoshinori Kitagawa1, Masae Itoh2, Bin Gotoh1 (1. Shiga University of Medical Science, 2. Nagahama Institute of Bio-science and Technology)

[P-PR-05]The difference of clinical severity and biomarkers of aseptic meningitis between cerebrospinal fluid virus genome positive and virus genome negative patients

*Norikatsu Hikita1, Toshiyuki Seto1, Takashi Hamazaki1 (1. Deprtment of Pediatrics, Osaka City University Hospital)

[P-PR-06]A 10-year study on circulation and genetic characteristics of coxsackievirus A6 and A16 in northern Vietnam, 2008-2017.

*Anh The Nguyen1, Thi Nguyen Hoa-Tran1, Anh Thi Hai Dao1, Chikako Kataoka2,3, Hiroyuki Shimizu4 (1. National Institute of Hygiene and Epidemiology, 2. Hokkaido University, Sapporo, Japan , 3. The Research Foundation for Microbial Diseases of Osaka University , 4. National Institute of Infectious Diseases, Tokyo, Japan)

[P-PR-07]Retrospective study on molecular phylogenetic tree analysis of parechovirus A3 and epidemiological characterization of patients in Osaka prefecture.

*Keiko Nakata1, Kenji Ymazaki2, Kazushi Motomura1 (1. Osaka Institute of Public Health, 2. Fuji microbe Research Institute, Inc.)

[P-PR-08]Parechovirus A3 prevalence in Toyama Prefecture estimated by detection from untreated sewage water and patients with various kinds of diseases in 2006 to 2017

*Masae Itamochi1, Noriko Inasaki1, Yumiko Saga1, Takahisa Shimada1, Kazunori Oishi1, Masatsugu Obuchi1 (1. Toyama Institute of Health)

[P-PR-09]Construction of a Saffold virus expressing green fluorescent protein UnaG

*Takako Okuwa1, Toshiki Himeda1, Koichi Utani1, Masaya Higuchi1 (1. Department of Microbiology, Kanazawa Medical University School of Medicine)

[P-PR-10]Neutralization test of gamma globulin against enterovirus D68 using suckling mice

*Hiroyuki Saito1, Wakako Akino1, Hiroko Sato1, Yoko Fujiya1, Takako Tanaka1, Ryoetsu Sato1, Susumu Sato1, Hiroyuki Shimizu2 (1. Akita Prefectural Research Center for Public Health and Environment, 2. Department of Virology II, National Institute of Infectious Diseases)

[P-PR-11]Measurement of neutralizing activity of intravenous immune globulin products against enterovirus D68 strains isolated in Japan

*Kazuhiro Yoshida1, Masamichi Muramatsu2, Katsumi Mizuta3, Hiroyuki Shimizu2 (1. Former National Institute of Infectious Diseases, 2. National Institute of Infectious Diseases, 3. Yamagata Prefectural Institute of Public Health)

[P-PR-12]The role of USP10 in regulation of antiviral response to Saffold virus infection

*Toshiki Himeda1, Takako Okuwa1, Koichi Utani1, Masaya Higuchi1 (1. Department of Microbiology, Kanazawa Medical University School of Medicine)

[P-PR-13]Comparison of glycolipid compositions between Theiler's murine encephalomyelitis virus binding and non-binding cells

*Kazuya Takeda1, Toshiki Himeda2, Tomonori Kaifu1, Yoshiro Ohara3, Akira Nakamura1 (1. Tohoku Medical and Pharmaceutical University, 2. Kanazawa Medical University, 3. Aoikai Sendai Hospital)

[P-PR-14]Stearoyl-CoA desaturase (SCD) 1 is required for efficient genome replication of Aichi virus.

*Jun Sasaki1, Takayuki Murata1 (1. Fujita Health University)

[P-PR-15]Cancer-specific apoptosis caused by the expression of Sindbis virus non-structural proteins

*Kengo Saito1, Yoshihumi Ohno1, Xue Ma1, Tomoko Ogawa1, Eiji Ido1, Ryosuke Murayama1, Hiroshi Shirasawa1 (1. Chiba University)

[P-PR-16]Roles of G3BP and stress granules on the replication of chikungunya virus

*Yusuke MAEDA1, Fusako Kitaura1, Yosiharu Matsuura1 (1. RIMD (Research Institute for Microbial Diseases), Osaka Univ.)

[P-PR-17]HGS in the ESCRT-0 complex interacts with Chikungunya viral proteins and regulates multiple steps of Chikungunya virus propagation.

*Shiho Torii1,2, Yasuko Orba1, Michihito Sasaki1, Yuji Wada3, Jody Hobson-Peters4, Roy A. Hall4, Hirofumi Sawa1,5,6 (1. Division of Molecular Pathobiology, Research center for Zoonosis Control, Hokkaido university, 2. Department of Molecular virology, Research Institute for Microbial Diseases, Osaka university, 3. Department of Pathology, National Institute of Infectious Diseases, 4. Australian Infectious Diseases Research Centre, Sch. of Chem. and Mol. Biosci., University of Queensland, 5. Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, 6. Global Virus Network (GVN))

[P-PR-18]Surveillance of arthropod-borne viruses in Mongolia

*Hiroshi Shimoda1, Junko Mizuno1, Keita Noguchi1, Yudai Kuroda1, Kango Tatemoto1, Milagros Virhuez Mendoza1, Ryusei Kuwata2, Ai Takano1, Boldbaatar Bazartseren3, Ken Maeda1,4 (1. Yamaguchi University, 2. Okayama University of Science, 3. Institute of Veterinary Medicine, Ulaanbaatar, 4. National Institute of Infectious Diseases)

[P-PR-19]Diverse endogenous flavivirus elements in field mosquitoes

*Yasuko Orba1, Bernard M Hang’ombe 2, Aaron S Mweene2, Michihito Sasaki1, Yuki Eshita1, Hirofumi Sawa1,3,4 (1. Research Center for Zoonosis Control, Hokkaido Univ., 2. School of Veterinary Medicine, Univ. of Zambia, 3. Global Virus Network, 4. GI-CoRE, Hokkaido Univ.)

[P-PR-20]Serological features of Zika virus infection in a Dengue hyper-endemic country, the Philippines.

Ava Kristy Sy Lee1, *Mary Ann Quinones1, Mary Anne Joy Reyes1 (1. Virology Department, Research Institute for Tropical Medicine)

[P-PR-21]Molecular Characteristics of Dengue Virus in Myanmar, 2017

*Aung Min Soe1,2,3, Mya Myat Ngwe Tun1, Theingi Win Myat3, Htin Lin3, Mo Mo Win3, Takeshi Nabeshima1, Shingo Inoue1,2, Kyaw Zin Thant3, Futoshi Hasebe1,2, Kouichi Morita1,2, Sujan Shresta4, Hlaing Myat Thu3, Moi Meng Ling1,2 (1. Department of Virology, Institute of Tropical Medicine and Leading Program, Nagasaki University, Nagasaki, Japan, 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 3. Department of Medical Research, Myanmar, Yangon, Myanmar, 4. La Jolla Institute of Allergy and Immunology, California, United States of America)

[P-PR-22]Transition of Dengue virus population in Vietnam

*Takeshi Nabeshima1, Thuy Thu Bui1, Mya Myat Ngwe Tun1, Mark Anthony D Luz1, Alonzo Maria Terrese Galvez2, Corazon C. Buerano2, Futoshi Hasebe3, Kouichi Morita1 (1. Department of Virology Institute of Tropical Medicine Nagasaki University , 2. Research and Biotechnology, St. Luke’s Medical Center, 3. ietnam Research station, Center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine)

[P-PR-23]Whole genome analysis of DENV-1 in 2017 outbreak in Northern Vietnam

*Taichiro Takemura1, Thach Co Nguyen2, Chau Ha Pham1, Phung Vu Mai Hoang3, Hang Le Khanh Nguyen3, Thuy Thi Thu Nguyen3, Takeshi Nabeshima2, Mai Thi Quynh Le3, Moi Ling Meng2, Koichi Morita2, Futoshi Hasebe1 (1. Vietnam Research Station, Institute of Tropical Medicine, Nagasaki University, 2. Department of Virology, Institute of Tropical Medicine, Nagasaki University, 3. Department of Virology, National Institute of Hygiene and Epidemiology, Vietnam)

[P-PR-24]Zika fever in Central Vietnam, 2014-2015

*Shashika Lavangi Wijesooriya1, Meng Ling Moi1, Co Thach Nguyen 1, T Thu Thuy Nguyen2, T Bich Hau Vu2, Takeshi Nabeshima1, Shingo Inoue 1, Taichiro Takemura1, T Thu Hang Pham2, T Quynh Mai Le 2, Kouichi Morita1, Futoshi Hasebe3,4 (1. Department of Virology, Inst. of Tropical Medicine, Nagasaki Univ., 2. Department of Virology, National Inst. of Hygiene and Epidemiology, Hanoi, Vietnam, 3. NIHE-Nagasaki Friendship Lab., Nagasaki Univ., Hanoi, Vietnam, 4. Vietnam Research Station of Nagasaki Univ., Nagasaki, Japan)

[P-PR-25]Sero-epidemiological study of Zika virus infection in Central Highlands Vietnam, 2017-2018

*THACH CO NGUYEN1,2,3,4, Meng Ling Moi1,2,3, Mai Thi Quynh Le 4, Thuy Thi Thu Nguyen 4, Hau Thi Bich Vu 4, Tuan Hai Nguyen 4, Quyen Do Pham4, Huong Minh Phu Ly2, Duoc Tho Pham 5, Thanh Ngoc Pham 5, Tuan Van Le 5, Futoshi Hasebe1,6, Kouichi Morita1,2,3 (1. Graduate School of Biomedical Sciences of Nagasaki University , 2. Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan., 3. Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases, Nagasaki University, Nagasaki, Japan, 4. National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam, 5. Tay Nguyen Institute of Hygiene and Epidemiology, Daklak, Viet Nam, 6. Vietnam Research Station, Center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine, Nagasaki University)

[P-PR-26]Activity situation of Japanese encephalitis virus in Kochi prefecture from 2016 to 2018

*Kiyohiko Matsui1, Chang-Kweng Lim2, Shigeru Tajima2, Masanori Daibata3 (1. Nitobe Bunka College, 2. Department of Virology 1, National Institute of Infectious Diseases, 3. Department of Microbiology and Infection, Kochi Medical School, Kochi University)

[P-PR-27]Survey of Japanese encephalitis virus in wild boars in Ishikawa prefecture, 2017-2019.

*Tomoyoshi KOMIYA1, Minako TAKAGI1, Takahiro MATSUMURA1, Hiroko TORINIWA1, Tsutomu TAKEGAMI2,3, Tetsuo NAKAYAMA4 (1. Hokuriku University, 2. Kanazawa Medical University, 3. Ishikawa Natural History Center, 4. Kitasato Institute for Life Sciences)

[P-PR-28]Laboratory diagnosis and retrospective study of tick-borne encephalitis cases in Hokkaido

*Hiroki Yamaguchi1, Kentaro Yoshii2, Rika Komagome1, Setsuko Ishida1, Masahiro Miyoshi1 (1. Div. of Virology, Dept. of Infectious Diseases, Hokkaido Institute of Public Health, 2. Lab. of Public Health, Faculty of Veterinary Med., Hokkaido Univ.)

[P-PR-29]OBESITY AND THE RISK OF SYMPTOMATIC VIRAL INFECTION OUTCOME

*Jenny G Low1,2,3, Shirin Kalimuddin1, Esther S Gan2, Kuan Rong Chan2, Eng Eong Ooi2,3 (1. Singapore General Hospital, 2. Duke-NUS Medical School, 3. Viral Research & Experimental Medicine Centre @SingHealth Duke-NUS)

[P-PR-30]Interaction of tick-borne encephalitis virus with blood brain barrier cell components

*Martin Palus1,2, Tomas Bily1, Marie Vancova1, Jana Elsterova1,2,3, Ludek Eyer1,2, Vaclav Hönig1,2, Daniel Ruzek1,2,3 (1. Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic, 2. Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic, 3. Faculty of Science, University of South Bohemia, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic)

[P-PR-31]Development of zika virus replicon cells expressing secretory luciferase

*Takayuki Hishiki1, Fumihiro Kato2, Rieko Suzuki1, Shigeru Tajima2, Chang-Kweng Lim2, Masayuki Saijo2, Tomohiko Takasaki3 (1. Department of Microbiology, Kanagawa Prefectural Institute of Public Health, 2. Department of Virology 1, National Institute of Infectious Diseases, 3. Kanagawa Prefectural Institute of Public Health)

[P-PR-32]Construction of a yellow fever virus subgenomic replicon system and characterization of cell lines harboring the replicon

*Kyoko Saito1, Masayoshi Fukasawa1, Ryosuke Suzuki2, Tomohiko Takasaki3, Kentaro Hanada1 (1. Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 2. Department of Virology II, National Institute of Infectious Diseases, 3. Kanagawa Prefectural Institute of Public Health)

[P-PR-33]Cell-based membrane fusion assay for flavivirus envelope proteins

*MIZUKI YAMAMOTO1,2, Takeshi Ichinohe3, Aya Watanabe1, Yusuke Fujinami1, Yasushi Kawaguchi4,2, Zene Matsuda5,2, Jun-ichiro Inoue1,2 (1. Division of Cellular and Molecular Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2. Research Center for Asian Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 3. Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 4. Division of Molecular Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 5. Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China)

[P-PR-34]Mechanistic analysis of small molecules that inhibit flavivirus E protein-mediated membrane fusion

*Yusuke Fujinami1, Mizuki Yamamoto1,2, Aya Watanabe1, Yasushi Kawaguchi3,2, Zene Matsuda4,2, Jun-ichiro Inoue1,2 (1. Division of Cellular and Molecular Biology, Department of Cancer Biology, The Institute of Medical Science, The University of Tokyo, 2. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, 3. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , 4. Laboratory of Structural Virology and Immunology, Institute of Chinese Academy of Sciences)

[P-PR-35]Screening of small chemical compounds inhibiting dengue virus (DENV) infection using DENV single-round infectious particles

*Miyuki Kimura1, Mami Matsuda2, Ryosuke Suzuki2, Takasuke Fukuhara3, Yoshiharu Matsuura3, Hideki Tani1 (1. Univ. of Toyama, 2. National Institute of Infectious Diseases, 3. Research Institute for Microbial Diseases, Osaka Univ.)

[P-PR-36]Identification of small molecular compounds for anti-dengue virus

*AKIHIKO SATO1,2, Haruaki Nobori1, Shinsuke Toba1,2, Kentaro Uemura1,2, Ryu Yoshida1, Takao Shishido1, Yasuko Oba2, Takahumi Sawa2,3 (1. Discovery & Disease Research Laboratory, Shionogi & Co. Ltd., 2. Research Center for Zoonosis Control, Hokkaido University, 3. GI-CoRe, Hokkaido University)

[P-PR-37]Inhibition of dengue virus replication by an interferon-inducible factor, IFI27

*Shoichi Sakaguchi1, Youichi Suzuki1, Akino Emi1, Takayuki Hishiki2, Hong Wu1, Takashi Nakano1 (1. Osaka Medical College, 2. Kanagawa Prefectural Institute of Public Health)

[P-PR-38]Determination of Dengue Immunity in participants, 5 years post third dose of Dengvaxia Vaccination by using FcgammaR-expressing cells

*Jincheng Chen1, Meng Ling Moi2, May Lin Oh1 (1. Changi General Hospital, 2. Nagasaki University)

[P-PR-39]Analysis of cross-reactivity of flaviviruses with sera of Japanese travelers who were diagnosed with dengue

*Takahiro Maeki1, Shigeru Tajima1, Makiko Ikeda1, Fumihiro Kato1, Satoshi Taniguchi1, Eri Nakayama1, Tomohiko Takasaki2, Kweng Chang Lim1, Masayuki Saijo1 (1. National Institute of Infectious Diseases, 2. Kanagawa Prefectural Institute of Public Health)

[P-PR-40]Evaluation of recombinant anti-dengue neutralizing antibodies that do not cause antibody-dependent enhancement of viral infection

Tomohiro Kotaki1, Takeshi Kurosu2, *Masanori Kameoka1 (1. Kobe University Graduate School of Health Sciences, 2. National Institute of Infectious Diseases)

[P-PR-41]Development of animal model for Zika virus vertical infection using embryonic day 9.5 pregnant Ifnar-/- mice

*Satoshi Taniguchi1, Eri Nakayama1, Yasuhiro Kawai2, Fumihiro Kato1, Takahiro Maeki1, Shigeru Tajima1, Masayuki Saijo1, Chang-Kweng Lim1 (1. Department of Virology I, National Institute of Infectious Diseases, Japan, 2. Division of Biosafety Control and Research, National Institute of Infectious Diseases, Japan)

[P-PR-42]Development of mouse models for maternal-fetal transmission of flavivirus infection and their utility for antiviral testing

*Satoru Watanabe1, Nicole Wei Wen Tan1, Kitti Wing Ki Chan1, Subhash G. Vasudevan 1 (1. Duke-NUS Medical School)

[P-PR-43]Evaluation of usefulness of Zika virus infected pregnant marmoset as a Zika virus vertical infection animal model

*Chang-Kweng Lim1, Satoshi Taniguchi1, Nor Azila Muhammad Azami1, Yasushi Ami4, Tadaki Suzuki2, Meng Ling Moi3, Yuriko Suzaki4, Noriyo Nagata2, Naoko Iwata2, Takahiro Maeki1, Shigeru Tajima1, Tomohiko Takasaki1, Ichiro Kurane1, Masayuki Saijo1 (1. Department of Virology 1, National Institute of Infectious Diseases, 2. Department of Pathology, National Institute of Infectious Diseases, 3. Nagasaki University, Institute of Tropical Medicine, 4. Division of Experimental Animal Research, National Institute of Infectious Diseases)

[P-PR-44]Characterization of tick-borne encephalitis virus isolated from Ixodes ovatus in Central area of Hokkaido in 2017, 2018

*Yuji Takahashi1, Shintaro Kobayashi1, Mariko Ishiduka1, Ryo Nakao2, Hiroaki Kariwa1, Kentaro Yoshii1 (1. Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, 2. Laboratory of Parasitology, Graduate School of Veterinary Medicine, Hokkaido University)

[P-PR-45]Changes in cytokine and chemokine profiles in mouse serum and brain, and in human neural cells, upon tick-borne encephalitis virus infection

*Daniel Ruzek1,2, Petra Pokorna Formanova2, Martin Palus1,2, Jiri Salat2, Vaclav Honig1,2, Michal Stefanik2, Pavel Svoboda2 (1. Inst. of Parasitology, Biology Centre, Czech Acad. Sci., Ceske Budejovice, Czech Rep., 2. Veterinary Res. Inst., Brno, Czech Rep.)

[P-PR-46]Characterization of cell death induced by zika virus protease

*Yutaro Yamaoka1,2, Satoko Matsunaga2, Akihide Ryo2 (1. Kanto Chemical Co., Inc., 2. Yokohama City University)

[P-PR-47]Dengue disease severity caused by elevated secreted NS1 arising from a single T164S mutation can be correlated to pertubations in NS1 lipoprotein structure

*Kitti Wing Ki Chan1,2, Satoru Watanabe1, Julien Pompon1, Sylvie Alonso2, Jan K. Marzinek3, Bo Burla4, Federico Torta4, An Qi Ngoh1, Peter J. Bond3, Markus R. Wenk4, Scott B. Halstead5, Dhanasekaran Vijayakrishna1,6, Eng Eong Ooi1, Subhash G. Vasudevan1,2 (1. Duke-NUS Medical School, 2. National University of Singapore, 3. Bioinformatics Institute (A*STAR), 4. Singapore Lipidomics Incubator (SLING), 5. Uniformed Services University of the Health Sciences, 6. Monash University)

[P-PR-48]RNF26 is a novel host E3 ligase targeting dengue virus nonstructural protein 4B.

*Hirotaka Takahashi1, Yuki Sameshima1, Shoichi Sakaguchi2, Youichi Suzuki2, Fumihiro Kato3, Takayuki Hishiki4, Subhash G Vasudevan5, Tatsuya Sawasaki1 (1. Proteo-Science Center, Ehime University, 2. Department of Microbiology and Infection Control, Osaka Medical College, 3. Department of Virology 1, National Institute of Infectious Diseases, 4. Department of Microbiology, Kanagawa Prefectural Institute of Public Health, 5. Program in Emerging Infectious Diseases, DUKE-NUS Medical School, Singapore)

[P-PR-49]Histidine residue at position 123 in genotype V Japanese encephalitis virus (GV JEV) E protein is associated with the high pathogenicity of the GV JEV in mice

*Shigeru Tajima1, Ken-ichi Shibasaki1, Satoshi Taniguchi1, Takahiro Maeki1, Eri Nakayama1, Chang-Kweng Lim1, Masayuki Saijo1 (1. National Institute of Infectious Diseases)

[P-PR-50]Molecular characterization of Barkedji and Barkedji-like virus isolated from mosquitoes in Zambia

*Christida Estu Wastika1, Michihito Sasaki1, Yasuko Orba1, Hirofumi Sawa1,2,3 (1. Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan, 2. Global Institution for Collaborative Research and Education (GI-CORE), Hokkaido University, Sapporo, Japan, 3. Global Virus Network, Baltimore, Maryland, USA)

[P-PR-51]Genomic analysis of sapoviruses detected in outbreaks and sporadic cases of acute gastroenteritis in Miyagi prefecture, Japan, 2004-2017

*Akie Sakagami1,2, Yo Ueki2, Mayuko Saito1, Hitoshi Oshitani1 (1. Tohoku University, 2. Miyagi prefectural institute of public health and environment)

[P-PR-52]Genetic analysis of norovirus GII.P7-GII.9 strain detected in Toyama Prefecture, 2018

*Noriko Inasaki1, Takahisa Shimada1, Yumiko Saga1, Masae Itamochi1, Masatsugu Obuchi1 (1. Toyama Institute of Health)

[P-PR-53]A longitudinal study on inapparent infection of norovirus for healthy volunteers

*KAZUSHI MOTOMURA1, RIKA TAKADA1, NAOMI SAKON1 (1. Osaka Institute of Public Health)

[P-PR-54]Calicivirus proteases induce TNF-α mRNA expression and regulate transcription factor

*Kei Sekiguchi1, Ryota Koba1, Yukinobu Tohya1 (1. Laboratory of Veterinary Microbiology, College of Bioresource Sciences, Nihon University)

[P-PR-55]Requirement of bile acids on human sapovirus growth in cultured cells

Hirotaka Takagi1, *Tomoichiro Oka1, Hiroyuki Saito2, Takayuki Kobayashi3, Mamoru Noda4 (1. National Institute of Infectious Diseases, 2. Akita Prefectural Research Center for Public Health and Environment, 3. Fukuoka Institute of Health and Environmental Sciences, 4. National Institute of Health Sciences)

[P-PR-56]Human norovirus propagation in human induced pluripotent stem cell-derived intestinal epithelial cells

*Shintaro Sato1 (1. RIMD, Osaka Univ.)

[P-PR-57]In silico screening of compounds that bind to the histo-blood group antigens binding site on norovirus capsid

*Masaru Yokoyama1, Osamu Kotani1, Hiromi Nakamura1, Hironori Sato1 (1. National Institute of Infectious Diseases)